ReviewBritish journal of clinical pharmacology2020

Opportunities for using in silico-based extended dosing regimens for monoclonal antibody immune checkpoint inhibitors.

Cody J Peer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.